Skip to main content

Table 1 Comparison of baseline characteristics between patients with normal and elevated hs-cTnT group

From: The clinical prognostic significance of hs-cTnT elevation in patients with acute ischemic stroke

 

hs-cTnT< 14 ng/L (398)

hs-cTnT≥14 ng/L (118)

OR(95%CI)

P*

Age, y(mean,SD)

65.36 ± 10.07

69.01 ± 9.77

 

0.00

Females,n(%)

205 (51.51)

58(49.15)

0.91 (0.60–1.37)

0.65

Men,n(%)

193(48.49)

60(50.85)

0.91(0.60–1.37)

0.65

Hypertension,patients,n(%)

287(72.11)

80(67.80)

0.81(0.52–1.27)

0.36

Current Smoking,n(%)

111(27.89)

38(32.20)

1.23(0.79–1.92)

0.36

Current alcohol drinking,n(%)

115(28.89)

38(32.20)

1.17(0.75–1.82)

0.49

Diabetes, n(%)

115(28.89)

39(33.05)

1.22(0.78–1.89)

0.39

Hyperlipidemia,n(%)

214(53.77)

60(50.85)

0.89(0.59–1.34)

0.58

ST/T change, n(%)

110 (27.64)

39(33.05)

1.293(0.83–2.01)

0.23

Insular stroke,n(%)

89(22.36)

63(53.39)

3.98(2.58–6.12)

0.00

Family history of stroke, n(%)

74(18,59)

27(22.88)

1.30(0.79–2.14)

0.30

NIHSS score(min-max)

2–25

2–30

  

NIHSS score(mean,SD)

8.82 ± 4.39

11.80 ± 5.21

 

0.00

  1. *Comparison between normal hs-cTnT group and elevated hs-cTnT group